SERPINA3 and acute myocardial infarction: In clinical practice, elevated circulating human SerpinA3 levels were significantly associated with adverse cardiovascular events after acute myocardial infarction (AMI), suggesting that human SerpinA3 may be a potential predictive marker for clinical manifestations of AMI (101).